Thyrotropin-releasing hormone regulation of thyrotropin beta-subunit gene expression involves intracellular calcium and protein kinase C

Biochemistry. 1991 Apr 16;30(15):3721-8. doi: 10.1021/bi00229a019.

Abstract

Our previous studies demonstrated TRH stimulation of TSH beta gene expression in rat pituitary cell cultures and GH3 tumor cells in a transient expression assay. To begin to characterize the gene-proximal elements of the pathways involved in TRH stimulation of TSH beta gene transcription, we examined the effects of factors that increase intracellular calcium concentration, [Ca2+]i, or activate protein kinase C on TSH beta promoter activity in transfected GH3 cells. TPA, a tumor-promoting phorbol ester, stimulated a dose-dependent increase in TSH beta promoter activity at 8 h similar to TRH (2-3-fold). TPA did stimulate protein kinase C activation without [Ca2+] mobilization. The calcium ionophore ionomycin increased cytoplasmic free [Ca2+] by stimulating both calcium influx and release from internal stores without affecting protein kinase C. Ionomycin also stimulated a dose-dependent increase (2-fold) in TSH beta promoter activity at 8 h. However, the voltage-dependent Ca2+ channel agonist Bay K 8644, which increased influx of extracellular calcium, had little or no effect on TSH beta gene expression until 48 h (5-fold). Similar effects on prolactin/mRNA levels were observed in these cells. Effects of these factors were not additive, suggesting a common pathway(s) to stimulate gene expression. Inhibition of intracellular calcium mobilization by treatment with 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate (TMB-8) inhibited ionomycin effects on gene expression without affecting phorbol ester activity, and, conversely, inhibition of protein kinase C activity by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride (H-7) or TPA desensitization blocked TPA effects without affecting ionomycin activity.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Animals
  • Calcium / metabolism*
  • Cells, Cultured
  • Cloning, Molecular
  • Enzyme Activation / drug effects
  • Gallic Acid / analogs & derivatives
  • Gallic Acid / pharmacology
  • Gene Expression Regulation* / drug effects
  • Ionomycin / pharmacology
  • Protein Kinase C / metabolism*
  • RNA, Messenger / metabolism
  • Rats
  • Substrate Specificity
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thyrotropin / biosynthesis
  • Thyrotropin / genetics*
  • Thyrotropin-Releasing Hormone / pharmacology*

Substances

  • RNA, Messenger
  • Ionomycin
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Thyrotropin-Releasing Hormone
  • Gallic Acid
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Thyrotropin
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate
  • Calcium